EyePoint

IPO

EyePoint is committed to developing therapeutics to improve the lives of patients with serious retinal disease.

Public · Watertown, United States · Founded 1987 · $60.5M raised

Employees
51–200
Founded
1987
Business Model
B2B
Total Funding
$60.5M
Last Round
$60.5M Corporate RoundMar 2018
Rounds
1
Type
Public

About

Clinical-stage biotech developing innovative sustained-release therapeutics for serious retinal diseases.

Summary

EyePoint is a biotechnology company based in Watertown, United States, founded in 1987. It has raised $60.5M in total across 1 round, most recently a $60.5M Corporate Round round in Mar 2018. Investors include Essex Woodlands Health Ventures.

Tech & App Stack

3 technologies & apps tracked

Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.

Sign up to view the funding chart

Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Secondary MarketPost-IPO Equity RoundJan 2021
$15.7M

Sign up to see all 5 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies